Retatrutide, the novel medication, is creating considerable buzz within the health management space. This drug combines the properties of two GLP-1 hormone stimulators, semaglutide , and is exhibiting significant efficacy in clinical trials . Early data suggest this treatment may facilitate more fat decline than available options , potentially pres